Investors

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Clinical update on Investigator-initiated SPiReLPhase 2 with Merck’s Keytruda® in relapse/refractory Diffuse Large B-cell Lymphoma (r/r DLBCL)

Dec 9, 2019 at 8:00 AM EST

Supporting Materials